Frederick A Jakobiec1, Pooja Bhat. 1. Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, 243 Charles Street, Boston, MA 02114, USA. Fred_Jakobiec@meei.harvard.edu
Abstract
PURPOSE: To determine through the use of immunohistochemistry the origins of retrocorneal cellular and fibrillar membranes. DESIGN: Retrospective, clinicopathologic study using surgically removed human corneal tissues. METHODS: Clinical records of patients' ocular diseases and surgical procedures were reviewed. Immunohistochemical staining was performed on 5 enucleated control globes, 32 penetrating keratoplasty specimens, and 6 Descemet stripping endothelial keratoplasty specimens to analyze: (1) the normal corneal epithelium, stroma, and endothelium; and (2) stromal scars, endothelial abnormalities, and retrocorneal membranes. Paraffin sections were stained with hematoxylin and eosin, periodic acid-Schiff, and Masson trichrome methods, and immunohistochemical analyses were performed with commonly available monoclonal and polyclonal antibodies for various cytokeratins (CKs), CD34, alpha-smooth muscle actin (SMA), and vimentin. RESULTS: Five subtypes among 28 retrocorneal membranes were characterized. Twelve fibrous (keratocytic) membranes of stromal origin had coarse collagen and immunostained negatively for all CKs, but strongly for vimentin and alpha-SMA, the last the only marker of diagnostic value. Nine metaplastic endothelium-derived membranes produced delicate collagenous matrices and immunoreacted with CK7, vimentin, and alpha-SMA. Two epithelial multilaminar or monolaminar membranes reacted with CK cocktail and wide-spectrum CK, mildly with CK7 (not observed in orthotopic surface epithelium), and negatively for alpha-SMA and vimentin. The final 2 categories were indeterminate or non-immunoreactive (3 specimens) and mixed (2 specimens). CONCLUSIONS: Immunohistochemistry can diagnose retrocorneal membranes of different provenances reliably in most cases. Clinical correlations established that these membranes develop after serious inflammatory disorders, prolonged wounding or ulcerations, and multiple surgeries (an average of 3.4 per patient). Copyright (c) 2010 Elsevier Inc. All rights reserved.
PURPOSE: To determine through the use of immunohistochemistry the origins of retrocorneal cellular and fibrillar membranes. DESIGN: Retrospective, clinicopathologic study using surgically removed human corneal tissues. METHODS: Clinical records of patients' ocular diseases and surgical procedures were reviewed. Immunohistochemical staining was performed on 5 enucleated control globes, 32 penetrating keratoplasty specimens, and 6 Descemet stripping endothelial keratoplasty specimens to analyze: (1) the normal corneal epithelium, stroma, and endothelium; and (2) stromal scars, endothelial abnormalities, and retrocorneal membranes. Paraffin sections were stained with hematoxylin and eosin, periodic acid-Schiff, and Masson trichrome methods, and immunohistochemical analyses were performed with commonly available monoclonal and polyclonal antibodies for various cytokeratins (CKs), CD34, alpha-smooth muscle actin (SMA), and vimentin. RESULTS: Five subtypes among 28 retrocorneal membranes were characterized. Twelve fibrous (keratocytic) membranes of stromal origin had coarse collagen and immunostained negatively for all CKs, but strongly for vimentin and alpha-SMA, the last the only marker of diagnostic value. Nine metaplastic endothelium-derived membranes produced delicate collagenous matrices and immunoreacted with CK7, vimentin, and alpha-SMA. Two epithelial multilaminar or monolaminar membranes reacted with CK cocktail and wide-spectrum CK, mildly with CK7 (not observed in orthotopic surface epithelium), and negatively for alpha-SMA and vimentin. The final 2 categories were indeterminate or non-immunoreactive (3 specimens) and mixed (2 specimens). CONCLUSIONS: Immunohistochemistry can diagnose retrocorneal membranes of different provenances reliably in most cases. Clinical correlations established that these membranes develop after serious inflammatory disorders, prolonged wounding or ulcerations, and multiple surgeries (an average of 3.4 per patient). Copyright (c) 2010 Elsevier Inc. All rights reserved.
Authors: Whayoung Lee; Alex Mammen; Deepinder K Dhaliwal; Cassandra Long; Yuko Miyagawa; David Ayares; David K C Cooper; Hidetaka Hara Journal: Xenotransplantation Date: 2016-11-05 Impact factor: 3.907
Authors: Christopher Smith; Daniel Kaitis; Jordan Winegar; Sean Edelstein; Matthew Council; George Kontadakis; Rocio Bentivegna; Mohamed Abou Shousha Journal: Ther Adv Ophthalmol Date: 2018-12-03